Halozyme Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence.
HALO Key Statistics
Stock Snapshot
The current Halozyme Therapeutics(HALO) stock price is $68.36, with a market capitalization of 8.14B. The stock trades at a price-to-earnings (P/E) ratio of 14.33.
During the trading session on 2025-12-23, Halozyme Therapeutics(HALO) shares reached a daily high of $69.15 and a low of $67.95. At a current price of $68.36, the stock is +0.6% higher than the low and still -1.1% under the high.
Trading volume for Halozyme Therapeutics(HALO) stock has reached 984.51K, versus its average volume of 2.73M.
The stock's 52-week range extends from a low of $46.26 to a high of $79.50.
The stock's 52-week range extends from a low of $46.26 to a high of $79.50.
HALO News
Claim 70% Off TipRanks This Holiday Season An update from Skye Bioscience ( (SKYE) ) is now available. On December 18, 2025, Skye Bioscience, Inc. entered int...
Halozyme Therapeutics Receives Composite Rating Upgrade 12/17/2025 Halozyme Therapeutics saw an improvement in its IBD SmartSelect Composite Rating Thursday, f...
Halozyme Therapeutics recently received FDA approval for RYBREVANT FASPRO, co-formulated with its ENHANZE platform for advanced EGFR-mutated non-small cell lung...
